Europe’s divisional patent game: how “final” decisions get delayed—and generics pay the price
Big Pharma doesn’t always need to win on the merits. Sometimes, it just needs to keep the clock from running.
That’s the uncomfortable reality behind Europe’s…

Pharma patent litigation used to be a $50M problem.
Now, for many companies, it’s a $5M problem—without “winning” every case or betting the company on a single strategy.
The shift isn’t luck. It’s discipline: how you design your patent portfolio, how y…

PBMs don’t just “manage formularies.” They quietly decide which drugs get preferred placement, which face tighter access, and which effectively get priced out of the market—often long before a patient ever sees a prescription.
And for pharma executives…

Mark Cuban’s “cost-plus” pricing isn’t just a new way to buy drugs—it’s a direct challenge to the patent playbook that has quietly governed U.S. healthcare for decades.
For years, the industry’s pricing logic has followed a familiar script: patents cre…

Should you file a provisional patent for your drug invention?
Here’s the honest answer: it depends—but most teams treat it like a checkbox when it’s actually a strategic lever that can either buy you time and optionality… or create avoidable risk later…

Don’t Wait for the Patent Cliff. Build Supply-Chain Resilience Years Before Drug Patent Expiration.
The “patent cliff” is often discussed like a single moment—an on/off switch when exclusivity ends and generic competition arrives. In reality, it’s a mu…

🚨 The 180-day FDA exclusivity race isn’t just a legal contest—it’s a timing game with real cashflow consequences.
If you’re a brand, generic, or biosimilar stakeholder, you already know the headlines: exclusivity can make or break launches, pricin…

The PBM Endgame: What Mark Cuban Got Right—and Why Pharma Still Isn’t Listening
The pharmacy benefit manager (PBM) debate has been stuck in a loop: everyone agrees the system is complicated, everyone claims they’re “fixing” it, and patients keep paying…

What long-term joint problems have been reported with Lipitor (atorvastatin)? Long-term joint side effects from Lipitor… https://www.Drugchatter.com/chat/47878/what-are-lipitor’s-long-term-joint-effects/

What long-term joint problems have been reported with Lipitor (atorvastatin)? Long-term joint side effects from Lipitor… https://www.Drugchatter.com/chat/47878/what-are-lipitor’s-long-term-joint-effects/